当前位置: 首页 > 期刊 > 《中医药临床杂志》 > 2011年第5期 > 正文
编号:12115706
柴胡疏肝散合六君子汤方治疗慢性乙型肝炎的临床研究
http://www.100md.com 2011年3月1日 杨世奎 杨尚东
第1页

    参见附件(1123KB,1页)。

     【摘要】 目的:观察柴胡疏肝散合六君子汤方对慢性乙型肝炎的临床疗效。方法:为将60例慢性乙型肝炎患者随机分为两组:对照组30例,以苦参素针剂肌肉注射,2ml/次,隔日1次,结合一般护肝药进行治疗;治疗组30例,在对照组治疗的基础上,加服柴胡疏肝散合六君子汤方,1剂/日,水煎分两次服用。两组均以180d为1个疗程。观察两组患者治疗前后临床症状、体征,肝功能、HBV-DNA、乙肝标志物的变化。结果:治疗组总有效率为93.3%,对照组为70.0%,两组比较,差异有统计学意义(P<0.05);两组患者治疗后与本组治疗前比较,谷丙转氨酶(ALT)、谷草转氨酶(AST)的恢复有统计学意义(P<0.01),总胆红素(TBil)的恢复有统计学意义(P<0.05);治疗组与对照组治疗后比较,谷丙转氨酶(ALT)、谷草转氨酶(AST)及总胆红素(TBil)的恢复无统计学意义(P>0.05)。治疗组HBV-DNA阴转率36.7%(11/30),HBeAg转阴率为23.3%(7/30),对照组分别为13.3%(4/30)和6.7%(2/30)。两组比较差异有统计学意义(P<0.05)。结论:方柴胡疏肝散合六君子汤对改善慢性乙型肝炎临床症状,恢复肝功能,促进HBV-DNA、HBeAg转阴有较好的作用。

    【关键词】 慢性乙型肝炎;柴胡疏肝散合六君子汤方;中医疗法

    Six Gentlemen Decoction Chaihushugan Powder Treatment of Chronic Hepatitis B

    Yang ShikuiYang Shangdong

    (Qingzhou City, Shandong Province People's Hospital, Shandong Qingzhou 262500)

    【Abstract】Objective:Chaihushugan Powder Liujunzi soup side effect of chronic hepatitis B patients. Methods:for the 60 patients with chronic hepatitis B were randomly divided into two groups: control group of 30 patients with intramuscular injection of matrine injection, 2ml / times, every other day 1, were treated with normal liver protection drugs; treatment group, 30 cases In the control group, based on the co-added services CHSGS Liujunzi soup side, 1 / day, twice taking the decoction. 180d both groups was 1 course of treatment. Before and after treatment were observed clinical symptoms and signs, liver function, HBV-DNA, HBV markers changes. Results:The total effective rate was 93.3%, 70.0% in the control group, the two groups, the difference was statistically significant (P<0.05); the two groups after treatment compared with the group before treatment, alanine aminotransferase (ALT), aspartate aminotransferase (AST) was significant recovery (P<0.01), total bilirubin (TBil) recovery was statistically significant (P<0.05); the treatment group compared with the control group after treatment, alanine aminotransferase (ALT ), aspartate aminotransferase (AST) and total bilirubin (TBil) no significant recovery (P>0.05). Treatment group, HBV-DNA negative rate of 36 ......

您现在查看是摘要介绍页,详见PDF附件(1123KB,1页)